Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Bioqual Inc. (BIOQ : OTC)

• Company Description    BIOQUAL, Inc., formerly Diagnon Corporation, develops, produces and sells diagnostic test kits incorporating monoclonal antibodies to diagnose certain anemias, infections, and parasitic diseases. Number of Employees:

• Price / Volume Information    Yesterday's Closing Price: $43.19 Daily Weekly Monthly 20 Day Moving Average: 42 shares Shares Outstanding: 0.89 (millions) Market Capitalization: $38.63 (millions) Beta: -0.11 52 Week High: $72.50 52 Week Low: $43.19 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -2.40% -6.80% 12 Week -21.47% -33.73% Year To Date -34.66% -38.61%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 9600 Medical Center Drive Suite 101 - ROCKVILLE,MD 20850 USA ph: 240-404-7654 fax: - irinfo@bioqual.com http://www.bioqual.com

• General Corporate Information    Officers Mark Lewis - Chief Executive Officer David A. Newcomer - Chief Financial Officer Mitchell L. Franklin - Chief Operating Officer David B. Landon - Director Vivek Shinde Patil - Director Peer Information Bioqual Inc. (CMTI) Bioqual Inc. (CMWLQ) Bioqual Inc. (AHG.) Bioqual Inc. (ROIX) Bioqual Inc. (M.DCE) Bioqual Inc. (DHSM) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-OUTP/HM CRE Sector: Medical CUSIP: 09065J101 SIC: 8731 Fiscal Year Fiscal Year End: May Last Reported Quarter: 02/01/25 Next Expected EPS Date: 09/19/25 Share - Related Items Shares Outstanding: 0.89 Most Recent Split Date: (:1) Beta: -0.11 Market Capitalization: $38.63 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 1.16% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.50 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 09/19/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 1.07 Price/Cash Flow: - Price / Sales: 0.79 EPS Growth vs. Year Ago Period: 238.71% vs. Previous Quarter: 177.21% Sales Growth vs. Year Ago Period: -8.54% vs. Previous Quarter: 23.15% ROE 05/31/25 - - 02/28/25 - -5.82 11/30/24 - -7.50 ROA 05/31/25 - - 02/28/25 - -3.79 11/30/24 - -4.90 Current Ratio 05/31/25 - - 02/28/25 - 5.08 11/30/24 - 3.73 Quick Ratio 05/31/25 - - 02/28/25 - 5.08 11/30/24 - 3.73 Operating Margin 05/31/25 - - 02/28/25 - -4.34 11/30/24 - -5.54 Net Margin 05/31/25 - - 02/28/25 - -4.34 11/30/24 - -5.54 Pre-Tax Margin 05/31/25 - - 02/28/25 - -6.38 11/30/24 - -8.03 Book Value 05/31/25 - - 02/28/25 - 40.53 11/30/24 - 39.48 Inventory Turnover 05/31/25 - - 02/28/25 - - 11/30/24 - - Debt-to-Equity 05/31/25 - - 02/28/25 - 0.00 11/30/24 - 0.00 Debt-to-Capital 05/31/25 - - 02/28/25 - 0.00 11/30/24 - 0.00

Powered by Zacks Investment Research ©